The Global Vitamin K Market was valued at USD 1.07 billion in 2025 and is estimated to grow at a CAGR of 8.5% to reach USD 2.4 billion by 2035.
Market growth is supported by rising awareness of the physiological importance of vitamin K in blood coagulation, bone strength, and cardiovascular wellness, alongside a growing incidence of cardiovascular conditions and nutrient deficiencies among older populations. Preventive healthcare trends and increased focus on micronutrient supplementation are further strengthening demand. Vitamin K has gained significant attention in clinical nutrition and wellness applications due to its role in regulating calcium metabolism and maintaining vascular integrity. As consumers increasingly prioritize long-term health outcomes, supplementation has moved beyond deficiency correction to proactive disease risk management. The market is also benefiting from expanding nutraceutical usage, improved formulation stability, and enhanced bioavailability across supplement and pharmaceutical products. Continuous innovation in production methods and ingredient sourcing is allowing manufacturers to deliver consistent quality while addressing rising global demand. Together, these factors are shaping a steadily expanding market landscape supported by both clinical utilization and consumer-driven wellness adoption.
Vitamin K represents a class of fat-soluble nutrients that are essential for activating proteins responsible for coagulation, bone mineralization, and cardiovascular balance. The market includes vitamin K1, primarily used in therapeutic and dietary formulations, and vitamin K2, which is increasingly incorporated into supplements designed to support skeletal and heart health. Both forms play a central role in regulating calcium transport and preventing improper mineral deposition, making them critical across preventive and therapeutic healthcare applications.
The vitamin K1 segment accounted for 68.4% share in 2025 and is expected to grow at a CAGR of 8.3% during 2026-2035. This segment continues to lead due to its established clinical importance in managing coagulation-related conditions and correcting deficiency states. Strong demand from pharmaceutical formulations and medical nutrition products supports its sustained adoption, while ongoing product optimization is reinforcing its relevance across healthcare settings.
The prothrombin deficiency segment generated USD 275.8 million in 2025. This segment maintained a leading position as vitamin K remains essential for the synthesis and activation of clotting factors required for normal blood function. Clinical reliance on vitamin K for managing coagulation disorders continues to drive consistent demand, particularly within hospital-based and acute care treatment protocols.
North America Vitamin K Market held 41.1% share in 2025. Regional leadership is supported by advanced healthcare systems, strong preventive health awareness, and widespread adoption of dietary supplementation. Continued investment in research, product development, and high-quality formulation technologies is reinforcing market growth, while consumer preference for scientifically backed nutritional solutions further strengthens regional demand.
Key companies operating in the Global Vitamin K Market include Pfizer, BASF SE, DSM-Firmenich, Lonza, Glanbia, Amphastar Pharmaceuticals, Gnosis by Lesaffre, Kappa Bioscience, Country Life (Kikkoman), Nature Made (Pharmavite), Nature’s Bounty (Nestlé Health Science), NOW Foods, Solgar, and Livealth Biopharma, with competitive positioning driven by diversified portfolios and global distribution capabilities. Companies active in the vitamin K market are strengthening their market position through continuous investment in formulation innovation, bioavailability enhancement, and product differentiation. Manufacturers are focusing on developing high-purity and stable vitamin K ingredients that meet pharmaceutical and nutraceutical quality standards. Strategic partnerships with healthcare providers and nutrition brands are expanding market reach, while geographic expansion into emerging regions is supporting long-term growth.
This product will be delivered within 2-4 business days.
Market growth is supported by rising awareness of the physiological importance of vitamin K in blood coagulation, bone strength, and cardiovascular wellness, alongside a growing incidence of cardiovascular conditions and nutrient deficiencies among older populations. Preventive healthcare trends and increased focus on micronutrient supplementation are further strengthening demand. Vitamin K has gained significant attention in clinical nutrition and wellness applications due to its role in regulating calcium metabolism and maintaining vascular integrity. As consumers increasingly prioritize long-term health outcomes, supplementation has moved beyond deficiency correction to proactive disease risk management. The market is also benefiting from expanding nutraceutical usage, improved formulation stability, and enhanced bioavailability across supplement and pharmaceutical products. Continuous innovation in production methods and ingredient sourcing is allowing manufacturers to deliver consistent quality while addressing rising global demand. Together, these factors are shaping a steadily expanding market landscape supported by both clinical utilization and consumer-driven wellness adoption.
Vitamin K represents a class of fat-soluble nutrients that are essential for activating proteins responsible for coagulation, bone mineralization, and cardiovascular balance. The market includes vitamin K1, primarily used in therapeutic and dietary formulations, and vitamin K2, which is increasingly incorporated into supplements designed to support skeletal and heart health. Both forms play a central role in regulating calcium transport and preventing improper mineral deposition, making them critical across preventive and therapeutic healthcare applications.
The vitamin K1 segment accounted for 68.4% share in 2025 and is expected to grow at a CAGR of 8.3% during 2026-2035. This segment continues to lead due to its established clinical importance in managing coagulation-related conditions and correcting deficiency states. Strong demand from pharmaceutical formulations and medical nutrition products supports its sustained adoption, while ongoing product optimization is reinforcing its relevance across healthcare settings.
The prothrombin deficiency segment generated USD 275.8 million in 2025. This segment maintained a leading position as vitamin K remains essential for the synthesis and activation of clotting factors required for normal blood function. Clinical reliance on vitamin K for managing coagulation disorders continues to drive consistent demand, particularly within hospital-based and acute care treatment protocols.
North America Vitamin K Market held 41.1% share in 2025. Regional leadership is supported by advanced healthcare systems, strong preventive health awareness, and widespread adoption of dietary supplementation. Continued investment in research, product development, and high-quality formulation technologies is reinforcing market growth, while consumer preference for scientifically backed nutritional solutions further strengthens regional demand.
Key companies operating in the Global Vitamin K Market include Pfizer, BASF SE, DSM-Firmenich, Lonza, Glanbia, Amphastar Pharmaceuticals, Gnosis by Lesaffre, Kappa Bioscience, Country Life (Kikkoman), Nature Made (Pharmavite), Nature’s Bounty (Nestlé Health Science), NOW Foods, Solgar, and Livealth Biopharma, with competitive positioning driven by diversified portfolios and global distribution capabilities. Companies active in the vitamin K market are strengthening their market position through continuous investment in formulation innovation, bioavailability enhancement, and product differentiation. Manufacturers are focusing on developing high-purity and stable vitamin K ingredients that meet pharmaceutical and nutraceutical quality standards. Strategic partnerships with healthcare providers and nutrition brands are expanding market reach, while geographic expansion into emerging regions is supporting long-term growth.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Type, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Route of Administration, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Distribution Channel, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Vitamin K market report include:- Amphastar Pharmaceuticals
- BASF SE
- Country Life (Kikkoman)
- DSM-Firmenich
- Glanbia
- Gnosis by Lesaffre
- Kappa Bioscience
- Livealth Biopharma
- Lonza
- Nature's Bounty (Nestle Health Science)
- Nature Made (Pharmavite)
- NOW Foods
- Pfizer
- Solgar
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | February 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 1.07 Billion |
| Forecasted Market Value ( USD | $ 2.4 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
